BioSphere Medical Inc.

1050 Hingham St
Rockland
MA
02370
United States
(781) 681-7900
Product(s): 
Develops embolic therapies for uterine fibroids
Employees: 
47 (75)
Established: 
1993
Ownership: 
Public
Exchange: 
NSDQ
symbol: 
BSMD
2004 Revenue: 
$14,158,000
2005 Revenue: 
$18,484,000
2006 Revenue: 
$22,891,000
2007 Revenue: 
$26,900,000
2008 Revenue: 
$29,258,000
Yahoo Quotes: 

CEO: 
Richard J. Faleschini
Management: 
Martin J. Joyce, EVP-Finance & Admin., CFO
Melodie R. Domurad, VP-Regulatory, Medical Affairs & Quality systems
Willard W. Hennemann, VP-New Product & Business Development
Peter Sutcliffe, VP-Manufacturing
Joel B. Weinstein, VP-Global Marketing & Sales
Biosphere Medical Inc.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp